drd4

Migration, Crosslink

📖

drd4

active

wiki page Created: 2026-04-02T07:19:26 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-drd4

📖 Wiki Page

gene1559 wordssynced 2026-04-02

drd4

<div class="infobox infobox-gene">
<div class="infobox-header">DRD4 — Dopamine Receptor D4</div>

<div class="infobox-row"><span class="infobox-label">Symbol</span><span class="infobox-value">DRD4</span></div>
<div class="infobox-row"><span class="infobox-label">Full Name</span><span class="infobox-value">Dopamine Receptor D4</span></div>
<div class="infobox-row"><span class="infobox-label">Chromosome</span><span class="infobox-value">11p15.5</span></div>
<div class="infobox-row"><span class="infobox-label">NCBI Gene ID</span><span class="infobox-value">[1819](https://www.ncbi.nlm.nih.gov/gene/1819)</span></div>
<div class="infobox-row"><span class="infobox-label">Ensembl ID</span><span class="infobox-value">ENSG00000169605</span></div>
<div class="infobox-row"><span class="infobox-label">UniProt ID</span><span class="infobox-value">[P21970](https://www.uniprot.org/uniprot/P21970)</span></div>
<div class="infobox-row"><span class="infobox-label">Receptor Class</span><span class="infobox-value">D2-like (Gi/o coupled)</span></div>
<div class="infobox-row"><span class="infobox-label">Expression</span><span class="infobox-value">Prefrontal cortex, Hippocampus, Hypothalamus, Amygdala</span></div>
</div>

Introduction

...

drd4

<div class="infobox infobox-gene">
<div class="infobox-header">DRD4 — Dopamine Receptor D4</div>

<div class="infobox-row"><span class="infobox-label">Symbol</span><span class="infobox-value">DRD4</span></div>
<div class="infobox-row"><span class="infobox-label">Full Name</span><span class="infobox-value">Dopamine Receptor D4</span></div>
<div class="infobox-row"><span class="infobox-label">Chromosome</span><span class="infobox-value">11p15.5</span></div>
<div class="infobox-row"><span class="infobox-label">NCBI Gene ID</span><span class="infobox-value">[1819](https://www.ncbi.nlm.nih.gov/gene/1819)</span></div>
<div class="infobox-row"><span class="infobox-label">Ensembl ID</span><span class="infobox-value">ENSG00000169605</span></div>
<div class="infobox-row"><span class="infobox-label">UniProt ID</span><span class="infobox-value">[P21970](https://www.uniprot.org/uniprot/P21970)</span></div>
<div class="infobox-row"><span class="infobox-label">Receptor Class</span><span class="infobox-value">D2-like (Gi/o coupled)</span></div>
<div class="infobox-row"><span class="infobox-label">Expression</span><span class="infobox-value">Prefrontal cortex, Hippocampus, Hypothalamus, Amygdala</span></div>
</div>

Introduction

The DRD4 gene encodes the dopamine D4 receptor, a G protein-coupled receptor (GPCR) that belongs to the D2-like family of dopamine receptors. First cloned in 1992[@van1992], the D4 receptor has attracted significant research interest due to its unique pharmacological profile—particularly its high affinity for the antipsychotic clozapine—and its well-documented polymorphisms that have been linked to various behavioral traits and neuropsychiatric disorders.

The D4 receptor is highly expressed in brain regions involved in executive function, attention, and reward processing, including the prefrontal [cortex](/brain-regions/prefrontal-cortex), [hippocampus](/brain-regions/hippocampus), and hypothalamus. It is notably polymorphic, with a variable number of tandem repeats (VNTR) in the third exon that has been extensively studied in relation to attention-deficit/hyperactivity disorder (ADHD), personality traits, and substance use disorders.

Gene Structure and Polymorphism

Genomic Organization

The DRD4 gene is located on chromosome 11p15.5 and spans approximately 3.5 kilobases. The coding sequence is organized into four exons, with the polymorphic region located in exon 3.

Variable Number Tandem Repeat (VNTR)

The most extensively studied polymorphism in DRD4 is a 48-base pair VNTR in exon 3, which can vary from 2 to 11 repeats[@van1993]. This polymorphism results in protein variants with different pharmacological properties:

| Repeats | Frequency | Functional Implications |
|---------|-----------|------------------------|
| 2-repeat | ~15% | Higher receptor density |
| 4-repeat | ~60% | Most common allele |
| 7-repeat | ~20% | Reduced receptor expression |

The 7-repeat allele has been associated with:

Reduced receptor efficiency in signal transduction
Altered response to dopamine agonists
Modified sensitivity to antipsychotic drugs[@li2007][@wang2013]

Regulatory Polymorphisms

Additional polymorphisms exist in the promoter region of DRD4:

-521 C/T variant affects transcriptional activity
-616 SNP influences receptor expression levels
Haplotype combinations modulate disease risk

Protein Structure and Signaling

Receptor Architecture

The D4 receptor exhibits the classic seven-transmembrane GPCR structure:

N-terminal extracellular domain: Contains glycosylation sites

Transmembrane domains (TM1-TM7): Form the ligand-binding pocket

Third intracellular loop (IL3): Longest loop, contains GRK phosphorylation sites

C-terminal tail: Involved in receptor desensitization and internalization

The D4 receptor has a notably longer third intracellular loop compared to other D2-like receptors, which contributes to its unique signaling properties.

G Protein Coupling

The D4 receptor couples primarily to Gi/o proteins[@oak2000]:

Gi/o activation: Inhibits adenylyl cyclase activity

cAMP reduction: Decreases intracellular cAMP levels

PKA inhibition: Reduces protein kinase A activity

Ion channel modulation: Regulates ion channel function through beta-gamma subunits

Beta-Arrestin Signaling

Like other dopamine receptors, D4 can signal through beta-arrestin pathways independently of G proteins:

MAPK activation:ERK1/2 phosphorylation
Receptor internalization: Clathrin-mediated endocytosis
Desensitization: GRK-mediated phosphorylation

Brain Expression and Distribution

Regional Distribution

D4 receptor expression shows distinct regional patterns[@tarazi1999]:

| Brain Region | Expression Level | Cell Type |
|--------------|------------------|-----------|
| Prefrontal Cortex | High | Pyramidal neurons, interneurons |
| Hippocampus | Moderate | CA1-CA3 pyramidal cells |
| Hypothalamus | High | Neuroendocrine neurons |
| Amygdala | Moderate | Principal neurons |
| Nucleus Accumbens | Low-Moderate | Medium spiny neurons |
| Striatum | Low | GABAergic neurons |

Cellular Expression

D4 receptors are primarily postsynaptic, located on:

Glutamatergic pyramidal neurons
GABAergic interneurons
Neuropeptide-containing neurons
Astrocyte processes (modest levels)

Normal Physiological Functions

Cognitive Functions

The D4 receptor plays important roles in cognitive processes:

Working Memory:

Modulates prefrontal cortical circuitry
Influences spatial working memory performance
Interacts with NMDA receptor signaling

Attention:

Regulates selective attention processes
Influences response inhibition
Modulates sensory gating

Reward and Motivation

D4 contributes to reward processing:

Modulates dopaminergic tone in reward pathways
Influences novelty-seeking behavior
Plays role in reinforcement learning

Neuroendocrine Regulation

In the hypothalamus, D4 regulates:

Prolactin secretion (tonic inhibition)
Vasopressin and oxytocin release
Food intake and energy balance

Disease Associations

Attention-Deficit/Hyperactivity Disorder (ADHD)

DRD4 is one of the most studied candidate genes for ADHD[@swanson1998]:

Genetic Evidence:

7-repeat allele associated with increased ADHD risk (OR ~1.4)[@li2007]
Meta-analyses confirm significant association
Rare transmitted variants show enrichment in ADHD families[@grigoroiu2015]

Mechanistic Links:

Altered dopamine signaling in prefrontal cortex
Impaired response inhibition
Enhanced reward sensitivity

Therapeutic Implications:

Methylphenidate effectiveness influenced by DRD4 genotype
Novel D4-selective agents under development

Parkinson's Disease

D4 receptors have complex roles in PD[@cho2013][@suzuki2013]:

Prefrontal Dysfunction:

D4 receptor density altered in PD prefrontal cortex
Contributes to cognitive impairment
May affect executive function deficits

Therapeutic Targeting:

D4 agonists investigated for neuroprotection
Potential role in levodopa-induced dyskinesias
Modulation of non-motor symptoms

Genetic Studies:

Some DRD4 variants associated with PD susceptibility
May influence age of onset
Interaction with other PD risk genes

Alzheimer's Disease

Emerging evidence links D4 to AD pathophysiology:

Cognitive Decline:

D4 receptor expression altered in AD cortex
May contribute to cholinergic dysfunction
Potential for cognitive enhancement strategies

Therapeutic Potential:

D4 modulation as cognitive enhancer
Interaction with amyloid processing
Neuroprotective strategies

Schizophrenia

D4 receptors have been studied in relation to schizophrenia[@seeman1995]:

Pharmacological Relevance:

High affinity for clozapine (D4 > D2 > D3)
D4 blockade may contribute to atypical antipsychotic efficacy
May explain reduced extrapyramidal side effects

Genetic Associations:

Linkage disequilibrium with schizophrenia
7-repeat allele may influence risk
Interaction with other dopamine receptor genes

Other Associations

Autism spectrum disorder: DRD4 variants linked to social behavior[@roohi2008]
Substance use disorders: 7-repeat allele associated with addiction vulnerability
Bipolar disorder: Genetic associations reported
Sleep disorders: D4 involved in sleep-dependent memory consolidation[@riemann2019]

Therapeutic Targeting

Current Pharmacological Agents

| Drug | Selectivity | Clinical Use |
|------|-------------|--------------|
| Clozapine | D4 > D2 > D3 | Treatment-resistant schizophrenia |
| Risperidone | D2/D4 antagonist | Schizophrenia, bipolar disorder |
| Aripiprazole | D2 partial agonist | Schizophrenia, depression |
| Methylphenidate | Indirect D4 modulation | ADHD |

Investigational Agents

D4-Selective Agonists:

A-412997: Full D4 agonist, cognitive enhancement
PD-168,077: D4-selective agonist
WK-23,847: Novel D4 agonist

D4-Selective Antagonists:

L-745,870: Research tool compound
FAUC213: Highly selective antagonist

Therapeutic Strategies

Cognitive Enhancement:

D4 agonists for working memory deficits
Combination with D1 agonists
Role in age-related cognitive decline

Neuroprotection:

D4 agonist-mediated neuroprotection
Anti-inflammatory effects
Mitochondrial function modulation

Animal Models

Mouse Models

Knockout Studies:

Drd4-/- mice show hyperactive phenotype
Impaired prepulse inhibition
Altered response to psychostimulants

Transgenic Models:

Human DRD4 transgenic mice
7-repeat knock-in mice
Conditional expression models

Behavioral Phenotypes

Enhanced novelty seeking
Altered reward processing
Impairments in attention tasks
Response to antipsychotic drugs

Research Directions

Genetic Studies

Whole-exome sequencing in ADHD families
Population-specific variant identification
Epigenetic regulation of DRD4

Neuroimaging

PET radioligands for D4 quantification
fMRI studies of D4 function
Developmental trajectory studies

Pharmacogenetics

Predicting treatment response
Personalized medicine approaches
Adverse effect prediction

References

[Van Tol HH et al., Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature. 1992](https://pubmed.ncbi.nlm.nih.gov/1326531/)

[Sunahara RK et al., Cloning of the cDNA for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature. 1991](https://pubmed.ncbi.nlm.nih.gov/1840644/)

[Oak JN et al., The dopamine D4 receptors: from structure to function. Cell Mol Neurobiol. 2000](https://pubmed.ncbi.nlm.nih.gov/10696518/)

[Faraone SV et al., Candidate gene studies of ADHD. Biol Psychiatry. 1999](https://pubmed.ncbi.nlm.nih.gov/10572216/)

[Seeman P et al., Dopamine D4 receptors: role in psychiatry. Neuropsychopharmacology. 1995](https://pubmed.ncbi.nlm.nih.gov/8573982/)

[Roohi J et al., The dopamine receptor D4 gene and autism. Am J Med Genet B Neuropsychiatr Genet. 2008](https://pubmed.ncbi.nlm.nih.gov/18449915/)

[Li D et al., Meta-analysis shows significant association between dopamine D4 receptor gene and ADHD. Mol Psychiatry. 2007](https://pubmed.ncbi.nlm.nih.gov/16924273/)

[Swanson JM et al., Molecular genetics of dopamine receptors and ADHD. Adv Pharmacol. 1998](https://pubmed.ncbi.nlm.nih.gov/9561015/)

[Wang E et al., The genetic architecture of selection on dopamine receptor D4. Hum Mol Genet. 2013](https://pubmed.ncbi.nlm.nih.gov/23515351/)

[Chang FM et al., The world-wide distribution of allele frequencies at the dopamine D4 receptor locus. Hum Genet. 1996](https://pubmed.ncbi.nlm.nih.gov/8688796/)

[Van Tol HH et al., Multiple dopamine D4 receptor variants in the human population. Nature. 1993](https://pubmed.ncbi.nlm.nih.gov/8096112/)

[Grigoroiu-Serbanescu M et al., Replication of rare transmitted DRD4 variants in a Romanian ADHD sample. Eur Child Adolesc Psychiatry. 2015](https://pubmed.ncbi.nlm.nih.gov/25557291/)

[Meador-Woodruff JH et al., Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology. 1996](https://pubmed.ncbi.nlm.nih.gov/8888064/)

[Marsden CA, Dopamine D4 receptor pharmacology and function. Ann NY Acad Sci. 1999](https://pubmed.ncbi.nlm.nih.gov/10415897/)

[Tarazi FI et al., Dopamine D4 receptors: localization and function in brain. Ann NY Acad Sci. 1999](https://pubmed.ncbi.nlm.nih.gov/10415898/)

[Riemann D et al., Dopamine D4 receptor and sleep-dependent memory consolidation. J Sleep Res. 2019](https://pubmed.ncbi.nlm.nih.gov/31102455/)

[Cho IH et al., Association between DRD4 polymorphism and Parkinson's disease susceptibility. J Neurol Sci. 2013](https://pubmed.ncbi.nlm.nih.gov/23558062/)

[Suzuki K et al., The influence of dopamine receptor D4 gene polymorphism on cognitive function in early Parkinson's disease. J Neural Transm. 2013](https://pubmed.ncbi.nlm.nih.gov/23400758/)

Pathway Diagram

The following diagram shows the key molecular relationships involving drd4 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

Pathway Diagram

The following diagram shows the key molecular relationships involving drd4 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

DRD4

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-drd4
kg_node_id	DRD4
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-2cace1614edb
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-drd4'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

15%

Debates

0

Incoming

3

Outgoing

10

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

drd4

drd4

Introduction

drd4

Introduction

Gene Structure and Polymorphism

Genomic Organization

Variable Number Tandem Repeat (VNTR)

Regulatory Polymorphisms

Protein Structure and Signaling

Receptor Architecture

G Protein Coupling

Beta-Arrestin Signaling

Brain Expression and Distribution

Regional Distribution

Cellular Expression

Normal Physiological Functions

Cognitive Functions

Reward and Motivation

Neuroendocrine Regulation

Disease Associations

Attention-Deficit/Hyperactivity Disorder (ADHD)

Parkinson's Disease

Alzheimer's Disease

Schizophrenia

Other Associations

Therapeutic Targeting

Current Pharmacological Agents

Investigational Agents

Therapeutic Strategies

Animal Models

Mouse Models

Behavioral Phenotypes

Research Directions

Genetic Studies

Neuroimaging

Pharmacogenetics

See Also

References

Pathway Diagram

Pathway Diagram

💬 Discussion